H-ALYLVCGER-OH

Ref. 3D-PP46878

Información del producto

• Nombre: H-ALYLVCGER-OH
• Sinónimos: NH2-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-OH

Descripción

Peptide H-ALYLVCGER-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ALYLVCGER-OH include the following: C-terminal modification of the insulin B: 11-23 peptide creates superagonists in mouse and human type 1 diabetes Y Wang , T Sosinowski, A Novikov - Proceedings of the , 2018 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1716527115 How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes Y Wang , T Sosinowski, A Novikov, F Crawford - Science , 2019 - science.orghttps://www.science.org/doi/abs/10.1126/sciimmunol.aav7517 Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice KE Pauken , JL Linehan , JA Spanier - The Journal of , 2013 - journals.aai.orghttps://journals.aai.org/jimmunol/article/191/10/4913/86896 Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice E Nikoopour , R Cheung, S Bellemore - European journal of , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201343986 Hidden in plain view: discovery of chimeric diabetogenic CD4 T cell neo-epitopes BK Reed, JW Kappler - Frontiers in Immunology, 2021 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.669986

• Marca: Biosynth